Preventing Otitis Externa: OTC Strategies for Consumer Health Brands

Otitis externa, commonly referred to as swimmer’s ear, is more than a seasonal inconvenience. It represents a recurring challenge in both clinical and consumer health contexts. While many cases are mild, the condition can cause significant discomfort, impact quality of life, and, if left untreated, lead to complications such as hearing loss. For consumer health brands aiming to develop effective over-the-counter (OTC) solutions, understanding the pathophysiology, regulatory constraints, and user expectations is key to offering safe, impactful, and commercially viable products.

Understanding Otitis Externa: Pathophysiology and Risk Factors

Otitis externa is an inflammation or infection of the external auditory canal, often resulting in pain, itching, and sometimes discharge and even fever. The most common otitis externa causes are bacterial infections, which account for up to 90% of cases. Fungal infections represent a smaller but clinically relevant proportion.

While it is often triggered by a moisture excess, the condition arises from a complex interaction of factors. The most prevalent risk factors include:

• Prolonged exposure to water (swimming, diving, humid environments)

• Use of hearing aids or earbuds

• Trauma caused by mechanical cleaning with inadequate tools (e.g., cotton swabs), self-scratching, foreign bodies, etc.

• Skin conditions like eczema, dermatitis or psoriasis

• Allergic reactions (e.g., to hair or skin care products)

The inflammation, skin maceration due to moisture, compromised skin’s natural barrier, etc. challenge the ear’s natural protective barrier (composed of cerumen -a mix of lipids and dead keratinocytes- and acidic pH), making it more susceptible to microbial invasion, especially by organisms such as Pseudomonas aeruginosa or Staphylococcus aureus. Recognising otitis externa symptoms early is crucial for timely intervention and prevention.

Over-the-Counter Solutions: Efficacy and Regulatory Landscape

The growing demand for self-care has increased interest in OTC options for preventing otitis externa and managing mild cases. However, the efficacy and safety of OTC ear drops for pain, cleansing, or prevention vary widely.

Key considerations for product developers include:

• Active ingredients: Alcohol-based drying agents are effective and safe if used correctly. Formulations including mild acidic compounds can help rebalance pH and prevent the growth of pathogens, while cerumenolytic agents soften and dissolve earwax, reducing the risk of blockage and secondary infection.
• Formulation tolerability: Products must be safe for repeated use and well tolerated in sensitive skin.
• Label clarity: Given the similarity between otitis externa symptoms and middle ear conditions to an untrained observer, labelling, instructions, and contraindications must be unambiguous.
• Regulatory status: Depending on the composition and claims, products may be classified as medical devices or medicines, with differing approval requirements.

Consumers and professionals alike often raise important questions when selecting or recommending a product:

• Can pharmacists help prevent otitis externa? 
• Can I buy antibiotic ear drops over the counter? 
• Do OTC ear drops work for ear infections? 

It’s important to note that while some OTC ear drops for clogged ears are effective for many, they are not substitutes for prescription-only antibiotic ear drops (such as ciprofloxacin ear drops) when bacterial infection is established. In most jurisdictions, you cannot buy antibiotic ear drops over the counter; these require a prescription due to the risk of resistance and the need for accurate diagnosis.

Regulatory agencies require that OTC products for earcare demonstrate both safety and efficacy, with clear labelling and instructions for use. Consumer health brands must ensure compliance with local and international guidelines, including evidence of clinical benefit and minimal risk of adverse effects.

Formulation Strategies for Consumer Health Brands

For consumer health brands aiming to lead in preventing otitis externa, formulation choices are critical. Products must respect the ear’s natural defences by avoiding harsh chemicals that disrupt the skin barrier or excessively alter the ear canal’s pH. They should offer broad-spectrum prophylactic efficacy, targeting both bacterial and fungal pathogens without contributing to resistance. 

Equally important is enhancing user compliance through formulations that are easy to administer, well-tolerated, and supported by clear educational materials. Addressing specific needs, such as variants for sensitive skin, frequent swimmers, or those prone to cerumen buildup, can improve user experience and adherence. But developing effective otitis externa ear drops requires more than a good active ingredient. 

Brands must also ensure stability and packaging compatibility, as ingredients must remain effective across storage conditions and be compatible with the container material. User-friendly delivery is also critical: dropper design, viscosity, and dosage must encourage correct use. Finally, a preventive positioning is essential; many infection cases can be avoided with proper use after swimming or exposure to moisture.

Market Trends and Opportunities in Otitis Externa Prevention

The global market for OTC ear care products is expanding, driven by increased awareness of ear health and the desire for self-care. Consumers are seeking the best over-the-counter medicine for swimmer’s ear and are turning to pharmacies for advice and effective solutions. Trends shaping the market include:

• Rising self-care awareness post-pandemic and pharmacy-first strategies

• Increased use of hearing devices and earbuds

• More active lifestyles, with exposure to pools, gyms and travel

• Innovation in delivery systems

For consumer health brands, the opportunity lies in connecting with consumers through practical, science-based education on otitis externa symptoms, encouraging early action over delayed treatment, and building strong collaborations with pharmacists as trusted points of care.

Prevention starts long before symptoms appear. If you’re in the business of marketing OTC ear care products, focus on what keeps the canal healthy, not just what treats it when it’s inflamed. Understand the science. Anticipate user needs. Deliver formulations that not only work but also build trust. 

At Mitelos, we develop evidence-based, well-tolerated ear care solutions that support prevention, empower healthcare professionals, and raise the bar for quality in consumer health. If you’re looking for a reliable partner to help develop, register, or scale your ear care portfolio, you can reach us at info@mitelos.es

References

Medina-Blasini Y, Sharman T. Otitis Externa. 2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID: 32310515.

MSD Manuals. Otitis externa aguda [Internet]. [cited 2025 Jun 9]. Available from: https://www.msdmanuals.com/es/professional/trastornos-otorrinolaringol%C3%B3gicos/trastornos-del-o%C3%ADdo-externo/otitis-externa-aguda 

Guía ABE. Otitis externa [Internet]. Asociación Española de Pediatría; [cited 2025 Jun 9]. Available from: https://www.guia-abe.es/temas-clinicos-otitis-externa